PXD061028-2

PXD061028 is an original dataset announced via ProteomeXchange.

Title	Proteomic changes of tumor drug-resistant cells after drug treatment
Description	Whole proteome and ribosome-nascent-chain complex (RNC) changes of A549 cisplatin-resistant cells after treated with aurintricarboxylic acid
HostingRepository	iProX
AnnounceDate	2025-02-20
AnnouncementXML	Submission_2025-07-16_00:39:07.805.xml
DigitalObjectIdentifier
ReviewLevel	Peer-reviewed dataset
DatasetOrigin	Original dataset
RepositorySupport	Unsupported dataset by repository
PrimarySubmitter	Keke Shang
SpeciesList	scientific name: Homo sapiens; NCBI TaxID: 9606;
ModificationList	methylated residue; methylthiolated residue
Instrument	timsTOF Pro

Revision	Datetime	Status	ChangeLog Entry
0	2025-02-20 18:41:31	ID requested
1	2025-05-06 06:35:58	announced
⏵ 2	2025-07-16 00:39:08	announced	2025-07-16: Add info.

Shang K, Chen Y, Jin J, Wang T, Zhang G, Aurintricarboxylic acid inhibits the malignant phenotypes of drug-resistant cells via translation regulation. Front Oncol, 15():1576685(2025) [pubmed]

submitter keyword: tumor drug-resistance, aurintricarboxylic acid,ribosome-nascent-chain complex (RNC),whole proteome

Gong Zhang
contact affiliation	Key Laboratory of Functional Protein Research of Guangdong Higher Education Institutes and MOE Key Laboratory of Tumor Molecular Biology, Institute of Life and Health Engineering,Jinan University
contact email	zhanggong-uni@qq.com
lab head
Keke Shang
contact affiliation	Key Laboratory of Functional Protein Research of Guangdong Higher Education Institutes and MOE Key Laboratory of Tumor Molecular Biology, Institute of Life and Health Engineering,Jinan University
contact email	shangkeke5365@126.com
dataset submitter

iProX dataset URI